[
  {
    "ts": null,
    "headline": "Push UPs [Stocks] Vs Pull DOWNs [Retail Sales]",
    "summary": "This week's review and preview: The S&P 500 and Nasdaq showed bullish behavior, with the Dow Jones leading YTD gains at 4.7%, despite weak retail sales data. Read the full report here.",
    "url": "https://finnhub.io/api/news?id=c31df8fe8b2fca463f42ecc3799b980a278e8518addeb12c05a3ccf4f73c16b1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739897952,
      "headline": "Push UPs [Stocks] Vs Pull DOWNs [Retail Sales]",
      "id": 132780121,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/948513030/image_948513030.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "This week's review and preview: The S&P 500 and Nasdaq showed bullish behavior, with the Dow Jones leading YTD gains at 4.7%, despite weak retail sales data. Read the full report here.",
      "url": "https://finnhub.io/api/news?id=c31df8fe8b2fca463f42ecc3799b980a278e8518addeb12c05a3ccf4f73c16b1"
    }
  },
  {
    "ts": null,
    "headline": "MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. ...",
    "url": "https://finnhub.io/api/news?id=379ef8d457b0ac0598f3566d336f7711bd0386bd7acc1cbd3e27232d92085503",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739890446,
      "headline": "MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit",
      "id": 132779400,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. ...",
      "url": "https://finnhub.io/api/news?id=379ef8d457b0ac0598f3566d336f7711bd0386bd7acc1cbd3e27232d92085503"
    }
  },
  {
    "ts": null,
    "headline": "Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial",
    "summary": "Merck and a woman suing the drugmakeragreed to halt a trial over alleged injuries from thedrugmaker's human papillomavirus vaccine in a case with ties toU.S. Department of Health and Human Services...",
    "url": "https://finnhub.io/api/news?id=72f1ab325b3f4289772c43b087c4a9a3504f1e1e734b03e0395c3ecbfb3c9225",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739890161,
      "headline": "Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial",
      "id": 132779383,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck and a woman suing the drugmakeragreed to halt a trial over alleged injuries from thedrugmaker's human papillomavirus vaccine in a case with ties toU.S. Department of Health and Human Services...",
      "url": "https://finnhub.io/api/news?id=72f1ab325b3f4289772c43b087c4a9a3504f1e1e734b03e0395c3ecbfb3c9225"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Sherwin-Williams Co. share losses lead Dow's 131-point drop",
    "summary": "UnitedHealth, Sherwin-Williams Co. share losses lead Dow's 131-point drop",
    "url": "https://finnhub.io/api/news?id=94cc7b8e2e5e9af34eb71ff375051129a16c10facf53c80475ad38658bda4cc1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739872740,
      "headline": "UnitedHealth, Sherwin-Williams Co. share losses lead Dow's 131-point drop",
      "id": 132767999,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Sherwin-Williams Co. share losses lead Dow's 131-point drop",
      "url": "https://finnhub.io/api/news?id=94cc7b8e2e5e9af34eb71ff375051129a16c10facf53c80475ad38658bda4cc1"
    }
  },
  {
    "ts": null,
    "headline": "American Century Growth Fund Q4 2024 Commentary",
    "summary": "We seek to invest in larger U.S. companies that are demonstrating their businesses are improving, as opposed to absolute levels of growth.",
    "url": "https://finnhub.io/api/news?id=fbbccef71b85345520452e8f1a85fd52955d8152883781001367f233e1a62ceb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739871300,
      "headline": "American Century Growth Fund Q4 2024 Commentary",
      "id": 132768474,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/682530865/image_682530865.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "We seek to invest in larger U.S. companies that are demonstrating their businesses are improving, as opposed to absolute levels of growth.",
      "url": "https://finnhub.io/api/news?id=fbbccef71b85345520452e8f1a85fd52955d8152883781001367f233e1a62ceb"
    }
  },
  {
    "ts": null,
    "headline": "GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'",
    "summary": "GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's rating from Buy to Strong Buy.",
    "url": "https://finnhub.io/api/news?id=79f9d082cf625de8b867702d2868dea83fc96c4cb55e6dce4daad22a8c0a5645",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739845293,
      "headline": "GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'",
      "id": 132765945,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/164210757/image_164210757.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's rating from Buy to Strong Buy.",
      "url": "https://finnhub.io/api/news?id=79f9d082cf625de8b867702d2868dea83fc96c4cb55e6dce4daad22a8c0a5645"
    }
  }
]